EVAX — Evaxion A/S
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1828253 ·
Denmark
Last close
$4.11
Market Cap
$34.28M
52W High
$4.75
52W Low
$2.96
ADV30
31,490
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -3,819,000 | -3,629,000 | 23,642,000 | 18,440,000 | 10,435,000 |
| Dec 2025 | 0 | — | -4,052,000 | -5,918,000 | 28,408,000 | 23,234,000 | 11,369,000 |
| Sep 2025 | 7,492,000 | — | 3,023,000 | 4,618,000 | 29,737,000 | 10,572,000 | 13,138,000 |
| Jun 2025 | 37,000 | — | -4,340,000 | -4,831,000 | 22,449,000 | 14,746,000 | 16,223,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-126,244,000
Inventory
—
Receivables
$1,051,000
ST Investments
—
EBIT TTM
$-8,733,000
Pretax Income TTM
$-8,619,000
Interest Exp TTM
$-114,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$7,528,000
EBITDA
$-8,824,500
Free Cash Flow
—
Enterprise Value
$1,682,963,840
Total Cash
$18,440,000
Total Debt
$0
Shares Out
8,340,215
Trailing EPS
$-1.00
Book Value
$2.04
ROE
-82.9%
ROA
-23.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 7,528,000 | -9,234,000 | -7,707,000 | 28,408,000 | 11,369,000 | — | -6,625,000 |
| Dec 2024 | 3,344,000 | -14,732,000 | -10,567,000 | 12,485,000 | 14,137,000 | — | -12,940,000 |
| Dec 2023 | 73,000 | -22,197,000 | -22,125,000 | 12,889,000 | 17,618,000 | — | -17,691,000 |
| Dec 2022 | 0 | -25,264,000 | -23,169,000 | 22,025,000 | 13,722,000 | — | -25,774,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.04
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TVGN | Tevogen Bio Holdings Inc. | $36.01M | $8.60 | — |
| ALGS | Aligos Therapeutics, Inc. | $30.93M | $5.74 | — |
| INMB | Inmune Bio, Inc. | $38.02M | $1.43 | — |
| ENZN | Viskase Holdings, Inc. | $38.02M | $5.75 | — |
| SNTI | Senti Biosciences, Inc. | $30.90M | $0.99 | — |
News headlines (Yahoo Finance, 1h cache)
European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading
2026-05-18 15:11 · Yahoo
European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading
2026-05-13 15:12 · Yahoo
Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress
2026-05-12 13:30 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise Friday
2026-05-08 15:10 · Yahoo
Evaxion (EVAX) Q1 2026 Earnings Transcript
2026-05-07 19:42 · Yahoo
Evaxion announces business update and first quarter 2026 financial results
2026-05-07 11:30 · Yahoo
Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026
2026-05-04 12:00 · Yahoo
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer
2026-04-27 12:00 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
2026-04-24 15:23 · Yahoo
European Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading
2026-04-22 15:13 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.